These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27165202)

  • 1. Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer.
    Farzaneh F; Noghabaei G; Barouti E; Pouresmaili F; Jamshidi J; Fazeli A; Emamalizadeh B; Darvish H
    Asian Pac J Cancer Prev; 2016; 17(S3):23-6. PubMed ID: 27165202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
    Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
    In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
    Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
    Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women].
    Hu MB; Xie W; Xiong B; Han DF; Li Y; Feng MH; Zhou YF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):351-5. PubMed ID: 16875543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
    Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
    Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.
    Sobczuk A; Romanowicz H; Fiks T; Połać I; Smolarz B
    Pol J Pathol; 2009; 60(4):163-7. PubMed ID: 20072949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of estrogen-metabolizing genes and breast cancer risk: a multigenic study.
    Han DF; Zhou X; Hu MB; Xie W; Mao ZF; Chen DE; Liu F; Zheng F
    Chin Med J (Engl); 2005 Sep; 118(18):1507-16. PubMed ID: 16232327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary isoflavone intake, polymorphisms in the CYP17, CYP19, 17beta-HSD1, and SHBG genes, and risk of breast cancer in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians.
    Iwasaki M; Hamada GS; Nishimoto IN; Netto MM; Motola J; Laginha FM; Kasuga Y; Yokoyama S; Onuma H; Nishimura H; Kusama R; Kobayashi M; Ishihara J; Yamamoto S; Hanaoka T; Tsugane S
    Nutr Cancer; 2010; 62(4):466-75. PubMed ID: 20432167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women.
    Hefler LA; Tempfer CB; Grimm C; Lebrecht A; Ulbrich E; Heinze G; Leodolter S; Schneeberger C; Mueller MW; Muendlein A; Koelbl H
    Cancer; 2004 Jul; 101(2):264-9. PubMed ID: 15241822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.
    Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B
    J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in steroid hormone pathway genes and mammographic density.
    Haiman CA; Hankinson SE; De Vivo I; Guillemette C; Ishibe N; Hunter DJ; Byrne C
    Breast Cancer Res Treat; 2003 Jan; 77(1):27-36. PubMed ID: 12602902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The polymorphism of genes of synthesis and metabolism of estrogens and the risk of breast cancer].
    Petchkovskiy EV; Shadrina AS; Boyarskih UA; Selezneva IA; Sinkina TV; Lazarev AF; Petrova VD; Filipenko ML
    Klin Lab Diagn; 2014 Feb; (2):19-23. PubMed ID: 25069228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of polymorphism of genetic markers of CYP19 and CYP17 with sporadic breast cancer].
    Artamonov VV; Liubchenko LN; Shabanov MA; Babenko OV; Nemtsova MV; Zaletaev DV
    Mol Biol (Mosk); 2003; 37(6):975-82. PubMed ID: 14714492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
    Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
    J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP17 (T34C), CYP19 (Trp39Arg), and FGFR2 (C906T) polymorphisms and the risk of breast cancer in south Indian women.
    Samson M; Rama R; Swaminathan R; Sridevi V; Nancy KN; Rajkumar T
    Asian Pac J Cancer Prev; 2009; 10(1):111-4. PubMed ID: 19469636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between estrogen-biosynthesis gene (CYP17, CYP19, HSD17beta1) polymorphisms and breast cancer].
    Wang YP; Li H; Li JY; Yuan P; Yang F; Lei FM; Pang Y; Guo J
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):899-903. PubMed ID: 20193327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
    Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic variants of CYP17 and CYP19A and risk of infertility in endometriosis.
    Szczepańska M; Wirstlein P; Skrzypczak J; Jagodziński PP
    Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1188-93. PubMed ID: 23809139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the rs10046 polymorphism of aromatase (CYP19) in premenopausal onset of human breast cancer.
    Zins K; Mogg M; Schneeberger C; Abraham D; Schreiber M
    Int J Mol Sci; 2014 Jan; 15(1):712-24. PubMed ID: 24402127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The polymorphisms of the CYP17 and CYP19 genes in endometrial cancer patients.
    Szyłło K; Smolarz B; Romanowicz-Makowska H; Kulig A
    Pol J Pathol; 2006; 57(1):35-40. PubMed ID: 16739881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.